YIYugo Iwaya

Yugo Iwaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yugo Iwaya has a total of 261 co-authors. Here are the top co-authors by number of shared publications:

  • Tadanobu Nagaya

    Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan

    11 shared publications
  • Yuto Shimamura

    Department of Gastroenterology and Hepatology Austin Health Melbourne Australia

    10 shared publications
  • Mai Iwaya

    Department of Laboratory Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan

    9 shared publications
  • Takeji Umemura

    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan

    7 shared publications
  • Takuma Okamura

    Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan

    7 shared publications
  • Takuma Okamura

    Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan

    7 shared publications

Latest Publications

  • Open Access

    Immunohistochemical analysis and scRNA-Seq identifies vascular endothelial CXCR4 expression as a predictor of poor prognosis in pancreatic ductal adenocarcinoma

    by Shunsuke Imamura, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Shinsuke Sugenoya, Hiroshi Sawaguchi, Yasuhiro Kuraishi, Tomoyuki Nakajima, Shotaro Komamura, Akira Nakamura, et al.

  • Risk-based pathology reporting after endoscopic submucosal dissection for early gastrointestinal cancer: international consensus standards

    by Kareem Khalaf, Huaqi Li, Mai Iwaya, Christine E Orr, Mark Schneider, Yugo Iwaya, Yuhong Yuan, Yutaka Saito, Yuto Shimamura, Helmut Messmann, et al.

    Background: Endoscopic submucosal dissection (ESD) enables en bloc resection of early gastrointestinal cancers and provides specimens suitable for precise pathological risk assessment. However, reporting remains variable for key parameters that determine curative resection and the need for additional treatment, including submucosal invasion depth and breadth, margin status, lymphovascular invasion, tumour budding, differentiation and use of ancillary stains. Objective: To develop practical international standards for pathology assessment and reporting of invasive carcinoma in ESD specimens. Design: An international panel of 42 experts, including 28 gastrointestinal pathologists and 14 therapeutic endoscopists from 15 countries, participated in a modified Delphi consensus process. Statements addressed measurement of invasion, margin assessment, staining, specimen handling, prognostic histological features and clinically relevant reporting. Results: 56 recommendations reached consensus across seven domains. The panel recommends using Sm1–Sm3 subclassification only when the muscularis propria is present; otherwise, submucosal invasion depth should be reported in micrometres, rounded to the nearest 100 µm. Submucosal invasion breadth should be reported in millimetres as an adjunct metric for future validation. Margin positivity should be defined as direct tumour contact with the inked surface, supported by standardised pinning, inking, complete embedding and parallel sectioning. H&E remains the baseline stain, with selective immunohistochemistry or elastic stains for equivocal lymphovascular invasion, distorted architecture or difficult margin interpretation. Tumour budding should be reported according to International Tumour Budding Consensus Conference criteria, and differentiation, histological subtype, lymphovascular invasion, perineural invasion and margin status should be integrated into composite risk assessment. Conclusions: These consensus standards provide immediately implementable, synoptic-ready pathology reporting criteria after ESD. By standardising measurement landmarks, margin terminology, ancillary stain use and reporting of adverse histological features, they aim to reduce interinstitutional variability, improve multidisciplinary decision-making and support future validation of risk models in early gastrointestinal cancer.


  • Adverse Events after Colorectal Polypectomy in Patients with Amyloidosis: Risk Assessment Using Propensity Score Matching

    by Hiroshi Sawaguchi, Tadanobu Nagaya, Tomoyuki Nakajima, Takuma Okamura, Mai Iwaya, Takeshi Uehara, Nagaaki Katoh, Yoshiki Sekijima, Yugo Iwaya

    Introduction: Amyloidosis may increase the risk of post-polypectomy bleeding due to mucosal and vascular fragility. We compared adverse events after colorectal polypectomy between patients with and without amyloidosis and explored risk factors for immediate post-polypectomy bleeding (IPPB). Methods: This retrospective investigation included 21 amyloidosis patients (71 polyps) and 110 non-amyloidosis patients (298 polyps) who underwent cold snare polypectomy (CSP) or endoscopic mucosal resection (EMR) between 2005 and 2024. Propensity score matching compared IPPB, delayed bleeding, and perforation. In the matched cohort, risk factors for IPPB were evaluated using generalized estimating equation (GEE) logistic regression clustered by patient ID. In the amyloidosis group, histological predictors (amyloid deposition and location) were assessed, and receiver operating characteristic (ROC) analysis evaluated polyp size. Results: IPPB occurred significantly more frequently in the amyloidosis group than in the matched non-amyloidosis group (p = 0.008). In multivariable GEE analysis, amyloidosis remained independently associated with IPPB (adjusted OR 3.20, 95% CI: 1.14–8.99; p = 0.027). In amyloidosis patients, muscularis mucosae deposition was associated with IPPB (p = 0.017); multivariate analysis suggested muscularis mucosae deposition (OR 6.55, 95% CI: 1.59–27.00; p = 0.009) and EMR (OR 8.26, 95% CI: 1.41–48.60; p = 0.020) as predictors. ROC analysis yielded an area under the ROC curve of 0.66 with a 6-mm cutoff. Conclusions: Amyloidosis was independently associated with increased IPPB risk after colorectal polypectomy. Muscularis mucosae deposition and EMR may help identify higher-risk lesions in amyloidosis, and CSP may be considered when feasible to reduce bleeding risk.

  • Open Access

    The Correlation of PBK Expression with an Immune-Activated Tumor Microenvironment and Outcome in Colorectal Cancer

    by Hiroshi Sawaguchi, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Tomoyuki Nakajima, Shotaro Komamura, Shunsuke Imamura, Yugo Iwaya, Shinsuke Sugenoya, Masato Kitazawa, et al.

    Background/Objectives: PDZ-binding kinase (PBK) regulates mitosis, but its clinical significance and cellular localization in colorectal cancer (CRC) remain unclear. We evaluated PBK expression in CRC tissues and examined its association with clinicopathological features, immune contexture, and outcomes. Methods: PBK expression was assessed by RNA in situ hybridization in tumors from 246 CRC patients. Associations with TNM stage, vascular invasion, MMR status (dMMR/pMMR), immune cell infiltration, and stromal programmed death-ligand 1 (PD-L1) were analyzed. Overall survival (OS) and recurrence-free survival (RFS) were evaluated using Kaplan–Meier and Cox models. Public single-cell RNA sequencing datasets were analyzed to identify PBK-expressing cell populations. Results: Among 246 cases, 75 (30.5%) showed high PBK expression. High PBK expression was associated with lower TNM stage, absence of vascular invasion, and dMMR status. High-PBK tumors showed an immune-activated microenvironment, including increased CD4+, CD8+, and FOXP3+ T-cell infiltration, higher stromal PD-L1 expression, and higher tumor-infiltrating lymphocyte scores. Single-cell analysis indicated that PBK expression was enriched mainly in proliferative tumor epithelial cell populations. High PBK expression was associated with longer OS and RFS and remained an independent favorable prognostic factor in multivariate analysis. Conclusions: PBK expression in CRC is linked to proliferative tumor epithelial states, an immune-activated microenvironment, and favorable outcomes, supporting its utility as a prognostic biomarker.


  • Open Access

    Characteristics and causes of post-endoscopy Barrett’s neoplasia: Retrospective multicenter study

    by Satoko Kako, Yugo Iwaya, Atsuhiro Hirayama, Takuma Okamura, Norikazu Arakura, Tomoaki Suga, Takayuki Watanabe, Akihiro Ito, Daichi Hara, Tadanobu Nagaya

    Missed high-grade dysplasia (HGD) or adenocarcinoma in Barrett's esophagus (BE) may have serious consequences, although the attributes of post-endoscopy Barrett's neoplasia (PEBN) remain unexplored. We analyzed the characteristics of Barrett’s neoplasia (BN) eluding detection during screening endoscopy. We retrospectively reviewed endoscopic images of BN, including HGD and adenocarcinoma, diagnosed at six centers in Nagano prefecture. Eligible patients had index endoscopic images obtained 7 to 36 months before BN diagnosis. Causes of PEBN were classified as perceptual error, in which BN was missed despite images taken where it was eventually diagnosed, or exposure error, whereby no images were obtained in the area of BN development. Among the 91 patients with BN, 31 were judged as having PEBN. The majority of PEBN cases were attributed to perceptual error (22 patients, 71%). Lesions within long-segment BE (LSBE) were significantly more likely to be overlooked due to exposure error (67% vs. 18%, P = 0.02), whereas lesions at the 0 to 3 o’clock position in short-segment BE (SSBE) tended to be missed due to perceptual error (76% vs. 33%, P = 0.04). Notably, 39% of perceptual error cases were misdiagnosed as esophagitis on index endoscopy. In the nine patients requiring surgery for PEBN, eight cases were attributed to perceptual error. PEBN occurring in LSBE was mostly overlooked because of inadequate observation, whereas PEBN at the 0 to 3 o'clock position in SSBE was frequently misdiagnosed as esophagitis. Bearing these results in mind may improve quality of endoscopic screening and reduce incidence of PEBN.

  • Open Access

    Underwater Endoscopic Mucosal Resection as a Salvage Strategy for a Non‐Lifting Early Sigmoid Colon Carcinoma After Failed Conventional Endoscopic Mucosal Resection: A Case Report

    by Hiroshi Sawaguchi, Takuma Okamura, Yugo Iwaya, Hiroyoshi Ota, Tadanobu Nagaya

    Endoscopic mucosal resection (EMR) has been widely adopted as an endoscopic treatment for colorectal tumors. However, in non‐lifting lesions, EMR often becomes technically challenging, leading to piecemeal resection or residual tumor. Recently, underwater EMR (UEMR) has been developed as a novel technique that allows mucosal and submucosal layers to float under water, facilitating snare resection without submucosal injection. UEMR has been reported to improve en bloc resection rates and shorten procedure time compared with conventional EMR, and its usefulness has been demonstrated in non‐lifting and residual lesions. We encountered a case in which a 78‐year‐old woman had a small IIa+IIc‐type lesion of the sigmoid colon that could not be completely removed by EMR at a previous hospital due to non‐lifting and snare slippage, resulting in only partial resection. She was subsequently referred to our hospital for further treatment. At our hospital, UEMR was successfully performed, achieving en bloc resection. Histopathological examination revealed well‐differentiated tubular adenocarcinoma with 560 µm submucosal invasion, negative resection margins, and no lymphovascular invasion, thus fulfilling the criteria for curative resection. This case highlights the illustrative and educational significance of applying UEMR, rather than endoscopic submucosal dissection, to achieve a safe and time‐efficient curative resection for a small non‐lifting colorectal carcinoma. UEMR may represent a potential salvage option in selected EMR‐difficult cases, although further accumulation of cases is warranted to clarify its role.

  • Potentially Causal Associations Between Extensive Gastric Atrophy and Esophageal Squamous Cell Carcinoma: A Nationwide Retrospective Cohort Study in Japan

    by Kenta Watanabe, Sho Fukuda, Dai Kubota, Nobutake Yamamichi, Yu Takahashi, Yoshitaka Watanabe, Kyoichi Adachi, Norihisa Ishimura, Tomoyuki Koike, Hideyuki Sugawara, et al.

    Objectives: A potential association between esophageal squamous cell carcinoma (ESCC) and gastric atrophy (GA) has been reported. However, most published studies have used case–control designs, leading to selection bias. This study aimed to investigate the causal association between ESCC and GA using a nationwide cohort. Methods: A retrospective cohort study was conducted on consecutive participants who underwent endoscopy at 17 health check‐up institutes in Japan between 2013 and 2017, with at least one follow‐up endoscopy by December 2022. GA was evaluated endoscopically and classified into atrophy‐free, closed‐type, and open‐type GA. The association between ESCC incidence and GA was estimated using the Kaplan–Meier method and Cox regression. Results: Among 33,461 participants, 17,398 (52.0%), 8257 (24.7%), and 7804 (23.3%) were classified into atrophy‐free, closed‐type GA, and open‐type GA, respectively. Seventy‐seven ESCCs were identified during a median 6‐year follow‐up period. The incidence of ESCC was 24 cases (0.024%/year) in the atrophy‐free group, 15 cases (0.031%/year) in the closed‐type GA group, and 38 cases (0.089%/year) in the open‐type GA group, with a significantly higher incidence observed in the open‐type GA group ( p < 0.001). After adjusting for established risk factors (e.g., age, sex, drinking, and smoking), open‐type GA, but not closed‐type GA, was an independent risk factor for ESCC (adjusted hazard ratio: 2.72, 95% confidence interval: 1.58–4.69). Conclusions: This Japanese nationwide cohort study provides new evidence suggesting a causal association between extensive GA and the subsequent development of ESCC.